The Journal of Neuroscience, December 10, 2008, 28(50):13662-13672; doi:10.1523/JNEUROSCI.4144-08.2008
Previous Article | Next Article 
Cellular/Molecular
Enhanced Sensitivity of Striatal Neurons to Axonal Transport Defects Induced by Mutant Huntingtin
Lu-Shiun Her1 and
Lawrence S. B. Goldstein1,2
1Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, and 2Howard Hughes Medical Institute, La Jolla, California 92093
Correspondence should be addressed to Dr. Lawrence S. B. Goldstein, University of California, San Diego, 9500 Gilman Drive, 414 Leichtag Biomedical Research Building, La Jolla, CA 92093-0683. Email: lgoldstein{at}ucsd.edu
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease linked to a polyQ (polyglutamine) expansion in the huntingtin protein. Although general brain atrophy is found in HD patients, the striatum is the most severely affected region. Loss or mutant forms of huntingtin were reported to disrupt fast axonal transport in Drosophila, squid, and mice. However, previous work did not resolve whether mutant huntingtin affects global axonal transport or only a subset of cargoes, nor did it resolve whether striatal neurons are preferentially sensitive to huntingtin-mediated defects. We used amyloid precursor protein (APP)–yellow fluorescent protein and brain-derived neurotrophic factor (BDNF)–mCherry fusion proteins as markers for fast axonal transport when huntingtin is altered. We found that movement of APP and BDNF is impaired in striatal and hippocampal, but not cortical, neurons from presymptomatic homozygous mutant mice carrying 150Q huntingtin knock-in mutations. In addition, loss of huntingtin disrupts APP axonal transport, whereas overexpression of wild-type, but not mutant, huntingtin enhances APP transport in all three types of neurons tested. These data suggest that a loss of wild-type huntingtin function in fast axonal transport plays important roles in the development of cell-type-specific defects in HD.
Key words: axonal transport; Huntington's disease; BDNF; striatum; cortex; mutant
Received Aug. 20, 2008;
revised Oct. 9, 2008;
accepted Oct. 24, 2008.
Correspondence should be addressed to Dr. Lawrence S. B. Goldstein, University of California, San Diego, 9500 Gilman Drive, 414 Leichtag Biomedical Research Building, La Jolla, CA 92093-0683. Email: lgoldstein{at}ucsd.edu
This article has been cited by other articles:

|
 |

|
 |
 
G. A. Morfini, M. Burns, L. I. Binder, N. M. Kanaan, N. LaPointe, D. A. Bosco, R. H. Brown Jr, H. Brown, A. Tiwari, L. Hayward, et al.
Axonal Transport Defects in Neurodegenerative Diseases
J. Neurosci.,
October 14, 2009;
29(41):
12776 - 12786.
[Abstract]
[Full Text]
[PDF]
|
 |
|